322 related articles for article (PubMed ID: 9894938)
1. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
Akpek EK; Ertoy D; Kalayci D; Hasiripi H
Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
[TBL] [Abstract][Full Text] [Related]
3. Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.
Rahimi F; Alipour F; Ghazizadeh Hashemi H; Hashemian MN; Mehrdad R
Arch Iran Med; 2009 Jan; 12(1):55-9. PubMed ID: 19111031
[TBL] [Abstract][Full Text] [Related]
4. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
Zaki AA; Farid SF
Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
[TBL] [Abstract][Full Text] [Related]
5. Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.
Birkholz ES; Goins KM; Sutphin JE; Kitzmann AS; Wagoner MD
Cornea; 2011 Jan; 30(1):37-41. PubMed ID: 20861726
[TBL] [Abstract][Full Text] [Related]
6. Treatment of ocular surface squamous neoplasia with Mitomycin C.
Gupta A; Muecke J
Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
[TBL] [Abstract][Full Text] [Related]
7. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
8. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
Tunc M; Erbilen E
Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
Tseng SH; Tsai YY; Chen FK
Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697
[TBL] [Abstract][Full Text] [Related]
10. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
Werschnik C; Lommatzsch PK
Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
[TBL] [Abstract][Full Text] [Related]
11. Topical mitomycin C for the treatment of conjunctival tumor.
Ozcan AA; Sizmaz S; Yagmur M
Ophthalmologica; 2007; 221(1):14-7. PubMed ID: 17183195
[TBL] [Abstract][Full Text] [Related]
12. Topical mitomycin-C for pterygia: is single application appropriate?
Rubinfeld RS; Stein RM
Ophthalmic Surg Lasers; 1997 Aug; 28(8):662-9. PubMed ID: 9268998
[TBL] [Abstract][Full Text] [Related]
13. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium.
Helal M; Messiha N; Amayem A; el-Maghraby A; Elsherif Z; Dabees M
Ophthalmic Surg Lasers; 1996 Aug; 27(8):674-8. PubMed ID: 8858633
[TBL] [Abstract][Full Text] [Related]
15. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
Ditta LC; Shildkrot Y; Wilson MW
Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
Bahrami B; Greenwell T; Muecke JS
Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
[TBL] [Abstract][Full Text] [Related]
17. Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva.
Shields CL; Demirci H; Marr BP; Masheyekhi A; Materin M; Shields JA
Arch Ophthalmol; 2005 Jan; 123(1):109-13. PubMed ID: 15642823
[No Abstract] [Full Text] [Related]
18. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
Wilson MW; Hungerford JL; George SM; Madreperla SA
Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
[TBL] [Abstract][Full Text] [Related]
19. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
Shields CL; Naseripour M; Shields JA
Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
[TBL] [Abstract][Full Text] [Related]
20. [Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
Rodríguez-Pérez C; Del Campo Z; Wolley-Dod C; Gris O
Arch Soc Esp Oftalmol; 2002 Dec; 77(12):685-8. PubMed ID: 12471516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]